体质调理能改菌群,菌群干预能改体质吗

Written by

in

Language

Evidence level: A

中医体质不是”天生定死”的标签,而是可被饮食、中药、益生菌与粪菌移植(FMT)推动的动态表型——问题只在于:按体质分型选干预,到底比”一刀切”好多少?

正文

上一篇文章我们论证了体质与肠道菌群互为因果、构成双向正反馈循环。一个自然的推论随之而来:既然循环是双向的,那么从”菌群”这一端推一把,是不是也能改变体质、进而改变疾病风险?这正是中医”调理偏颇体质”的古老直觉——只是过去没有仪器能回答”调理到底改变了什么”。

第一块拼图:体质评分确实可被干预推动

2021 年南方医科大学团队的一项随机临床试验给出了教科书级的证据。研究从 5185 人的前瞻队列中筛出 60 名健康的阳虚质大学生,随机分组后干预组接受桂附地黄丸加生活方式调理一个月。结果不仅阳虚症状积分显著下降,且干预后肠道菌群多样性与结构明显恢复——原本阳虚质偏高的 Bacteroidetes 与 Bacteroides 丰度回落,菌群与尿代谢组”部分恢复到平和质样水平”,一年随访疗效仍保持(PMID 34107861)。这条证据的含金量在于:干预同时改动了体质量表评分和菌群指纹,两者方向一致。

2025 年北京中医药大学深圳医院的 RCT 补齐了另一块:78 名受试者(气虚质 63 例、平和质 15 例)接受气虚调体方干预后,气虚质得分显著下降,血清 IgA、IgG 上升,转录组锁定 8 个免疫相关治疗靶基因,分子对接确认木犀草素、槲皮素等成分可稳定结合靶点(PMID 41246353)。也就是说,”调理改变体质”不再只是主观量表的事,它有免疫指标和转录组的客观依据。

第二块拼图:菌群干预确实可改变代谢结局

反过来,从菌群端直接下手也有硬数据。2021 年《自然·医学》发表的重度肥胖合并代谢综合征 2 期双盲 RCT 显示,口服粪菌移植联合低发酵纤维,6 周即显著改善胰岛素敏感性(HOMA2-IR 3.77→3.16),效果独立于纤维本身(PMID 34226737)。更关键的是长期维度:青少年肥胖 FMT 试验的 4 年随访中,FMT 组腰围缩小 10.0 cm、全身脂肪减少 4.8%、代谢综合征严重度评分下降 0.58、炎症标志物 hs-CRP 下降 68%,供体来源菌株在受者肠道持续定植(PMID 40877311)。菌群干预不是”换了个菌群就完事”,而是把代谢轨道整体扳动了一下。

中医自身也有对号入座的实践:2025 年泽泻汤加减治疗痰湿质 1 期高血压的 30 例临床研究显示,42 天干预后血压下降、菌群多样性上升、SCFA 显著升高,机制指向”肠-免疫-肾轴”(PMID 40606611)。痰湿质是代谢病的高危体质,这个方子恰好从菌群通道起效——中医辨证选方,客观上就是在做”按体质定向的菌群干预”。

第三块拼图:把两件事接起来

至此逻辑闭环浮现:体质评分可被干预推动(中药+生活方式),菌群干预可改变代谢结局(FMT/膳食纤维),且同一套干预同时作用于体质量表和菌群指纹(阳虚质 RCT)。体质、菌群、疾病三者构成一个可被外部干预旋动的环。但必须诚实指出缺口:至今没有一项头对头 RCT 直接比较”按体质分型选菌群干预”与”不按体质分型的一刀切干预”,因此”辨证选菌”优于”泛用菌”的增量价值,仍是待证假设而非事实。

证据与局限

已验证: 中药+生活方式干预可降低偏颇体质评分并同步恢复菌群多样性(PMID 34107861);体质干预存在免疫学与转录组客观标志(PMID 41246353);FMT 联合纤维可改善胰岛素敏感性(PMID 34226737),长期随访显示代谢与炎症结局改善(PMID 40877311);痰湿质方剂可从肠-免疫-肾轴调菌群降压(PMID 40606611)。

部分验证: 干预后菌群”恢复到平和质样水平”是近似表述,尚无研究把九种体质的菌群指纹做成金标准对照库;FMT 研究结果存在不一致(部分试验临床指标无差异),效应量受供体、剂量、随访时长调节。

待验证: 按体质分型选菌群干预 vs 一刀切干预的头对头 RCT;菌群干预改变体质量表评分的剂量-反应曲线;不同体质对同一菌群干预的应答差异(应答者/无应答者分层);干预停止后体质与菌群的回落动力学。

相关阅读

证据等级: A
参考文献: PMID 34107861, PMID 41246353, PMID 34226737, PMID 40877311, PMID 40606611


免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。

Can Microbiome Intervention Modify Physiological Constitution

Evidence level: A

Traditional Chinese Medicine (TCM) constitution is not a “fixed-at-birth” label, but a dynamic phenotype that can be modulated by diet, herbal medicine, probiotics, and fecal microbiota transplantation (FMT). The question remains: to what extent does selecting interventions based on constitution typing outperform a “one-size-fits-all” approach?

Main Text

In the previous article, we argued that constitution and gut microbiota are causally linked, forming a bidirectional positive feedback loop. A natural inference follows: if the loop is bidirectional, does pushing from the “microbiome” end also alter constitution and subsequently disease risk? This aligns with the ancient intuition of TCM regarding “adjusting imbalanced constitutions”—the only gap was the lack of instrumentation to answer what exactly constitutes an “adjustment.”

First Piece of the Puzzle: Constitution Scores Can Be Driven by Intervention

A 2021 randomized controlled trial (RCT) by a team at Southern Medical University provided textbook-level evidence. Screening 60 healthy students with Yang Deficiency constitution from a prospective cohort of 5,185 individuals, the intervention group received Gui Fu Di Huang Wan combined with lifestyle adjustments for one month. Results showed a significant reduction in Yang Deficiency symptom scores, alongside a clear restoration of gut microbiota diversity and structure. Specifically, abundances of Bacteroidetes and Bacteroides, which were typically elevated in Yang Deficiency, decreased, and the microbiome and urinary metabolome partially recovered to levels resembling “Peaceful Constitution” (Ping He Zhi), with efficacy maintained at one-year follow-up (PMID 34107861). The evidentiary value lies in the fact that intervention simultaneously altered constitution score metrics and microbiome fingerprints, moving in the same direction.

A 2025 RCT by Shenzhen Hospital of Beijing University of Chinese Medicine completed another piece of the puzzle: 78 participants (63 with Qi Deficiency, 15 with Peaceful Constitution) showed a significant decrease in Qi Deficiency scores after intervention with a Qi-tonifying formula. Serum IgA and IgG levels increased, transcriptomics identified 8 immune-related therapeutic target genes, and molecular docking confirmed that compounds such as luteolin and quercetin could stably bind to these targets (PMID 41246353). Thus, “adjustment altering constitution” is no longer merely a matter of subjective scales; it now has objective bases via immune markers and transcriptomics.

Second Piece of the Puzzle: Microbiome Intervention Can Indeed Alter Metabolic Outcomes

Conversely, direct intervention from the microbiome end also yields hard data. A 2021 Phase II double-blind RCT published in Nature Medicine regarding severe obesity with metabolic syndrome showed that oral FMT combined with low-fermentable fiber significantly improved insulin sensitivity (HOMA2-IR 3.77→3.16) within six weeks, an effect independent of the fiber itself (PMID 34226737). More critically regarding the long-term dimension, a 4-year follow-up in an adolescent obesity FMT trial showed that the FMT group experienced a waist circumference reduction of 10.0 cm, total body fat reduction of 4.8%, a decrease in metabolic syndrome severity score by 0.58, and a reduction in the inflammatory marker hs-CRP by 68%, with donor-derived strains persistently colonizing the recipient gut (PMID 40877311). Microbiome intervention is not merely “changing the microbiome and finishing the job,” but rather shifting the entire metabolic trajectory.

TCM itself also has practical applications matching this logic: a 2025 clinical study of 30 cases treating Stage 1 Phlegm-Dampness constitution hypertension with modified Ze Xie Tang showed that after 42 days of intervention, blood pressure decreased, microbiota diversity increased, and short-chain fatty acids (SCFA) significantly rose, with mechanisms pointing to the “gut-immune-kidney axis” (PMID 40606611). Phlegm-Dampness constitution is a high-risk phenotype for metabolic diseases; this formula effectively acts through the microbiome channel—objectively constituting “targeted microbiome intervention based on constitution typing.”

Third Piece of the Puzzle: Connecting the Two Events

The logical loop now emerges: constitution scores can be driven by intervention (herbal medicine + lifestyle), microbiome intervention can alter metabolic outcomes (FMT/dietary fiber), and the same interventions act simultaneously on constitution scores and microbiome fingerprints (Yang Deficiency RCT). Constitution, microbiome, and disease form a cycle that can be rotated by external intervention. However, one must honestly acknowledge the gap: no head-to-head RCT has yet directly compared “microbiome intervention selected by constitution typing” versus “one-size-fits-all microbiome intervention.” Therefore, the incremental value of “syndrome differentiation-guided microbial selection” over “generalized microbial use” remains a hypothesis awaiting proof rather than an established fact.

Evidence and Limitations

Verified: Herbal medicine + lifestyle interventions can reduce imbalanced constitution scores while simultaneously restoring microbiota diversity (PMID 34107861); constitution interventions exhibit objective immunological and transcriptomic markers (PMID 41246353); FMT combined with fiber can improve insulin sensitivity (PMID 34226737), with long-term follow-ups showing improvements in metabolic and inflammatory outcomes (PMID 40877311); Phlegm-Dampness formulas can modulate microbiota to lower blood pressure via the gut-immune-kidney axis (PMID 40606611).

Partially Verified: The description of post-intervention microbiota “returning to Peaceful Constitution levels” is an approximation; no study yet has established a gold-standard reference library comparing microbiome fingerprints across the nine constitutions. FMT study results show inconsistencies (some trials showed no difference in clinical indicators), with effect sizes modulated by donor source, dosage, and follow-up duration.

To Be Verified: Head-to-head RCT comparing constitution-typed microbiome intervention vs. one-size-fits-all intervention; dose-response curves for microbiome intervention effects on constitution score metrics; differential responses to the same microbiome intervention across different constitutions (stratified by responders/non-responders); the kinetics of reversion for both constitution and microbiota after intervention cessation.

Related Reading

Evidence Level: A
References: PMID 34107861, PMID 41246353, PMID 34226737, PMID 40877311, PMID 40606611


Disclaimer: This article compiles traditional knowledge and scientific literature for comparison and research-design discussion only. It is not medical advice and cannot replace professional diagnosis or treatment. Effect sizes, frequency ranges and exposure conclusions cited here are largely inferences at the research-report level, and individual circumstances vary widely. If you have any discomfort or health concerns, please consult a physician.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *